Joshua Brody

Has grant

Icahn School of Medicine at Mount Sinai

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

Understanding and Preventing FL Antigen Escape After Immunotherapy

Open Date: 2023-04-01

Close Date: 2026-03-31

Articles (10)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Collaborators (7)

Girish Venkataraman

Asst Professor

University of Chicago Pritzker School of Medicine

UNITED STATES

View details

Gilles Salles

Lymphoma Service, Chief

Memorial Sloan Kettering Cancer Center

UNITED STATES

View details

Tim Luetkens

Associate Professor

University of Maryland

UNITED STATES

View details

Justin Kline

University of Chicago

UNITED STATES

View details

Kevin Harrington

Head of Division of Radiotherapy and Imaging

Institute of Cancer Research

UNITED KINGDOM

View details

Amitkumar Mehta

Assistant professor

The University of Alabama

UNITED STATES

View details

Paul M. Barr

University of Rochester

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Joshua Brody

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (10)

Phase I and II Clinical Studies of the STING Agonist Ulevostinag with and without Pembrolizumab in Participants with Advanced or Metastatic Solid Tumors or Lymphomas

Epcoritamab plus GemOx in transplant-ineligible relapsed/refractory DLBCL: results from the EPCORE NHL-2 trial

Nivolumab plus brentuximab vedotin for relapsed/refractory peripheral T-cell lymphoma and cutaneous T-cell lymphoma

T-cell States, Repertoire, and Function in Classical Hodgkin Lymphoma Revealed through Single-Cell Analyses

Phase I Study of GS-3583, an FMS-like Tyrosine Kinase 3 Agonist Fc Fusion Protein, in Patients with Advanced Solid Tumors

Pembrolizumab for patients with non-Hodgkin lymphoma: phase 1b KEYNOTE-013 study

Low-affinity CAR T cells exhibit reduced trogocytosis, preventing rapid antigen loss, and increasing CAR T cell expansion

In CAR T cell-treated lymphomas, the T cell rich get richer

Cancer vaccines: the next immunotherapy frontier

Biomarkers of response to ibrutinib plus nivolumab in relapsed diffuse large B-cell lymphoma, follicular lymphoma, or Richter's transformation

Collaborators (7)

Girish Venkataraman

Gilles Salles

Tim Luetkens

Justin Kline

Kevin Harrington

Amitkumar Mehta

Paul M. Barr

Make your next move.